How to Write Effective 483 and Warning Letter Responses

This course will review the proper structure of the response to ensure the regulatory agency's expectations are met and the submission process. 

Kelly Thomas
Instructor:
Kelly Thomas
Date:
Monday, April 8, 2019
Time:
10:00 AM PDT | 01:00 PM EDT
Duration:
90 Minutes

More Trainings by this Expert   Product Id : 502475

Price Details
$150 Live
$290 Corporate Live
$190 Recorded
$390 Corporate Recorded
Combo Offers
Live + Recorded
$289 $340 Live + Recorded
Corporate (Live + Recorded)
$599 $680 Corporate
(Live + Recorded)
Price Detail Options
Overview:

This 90-minute course will discuss the importance of developing and submitting a robust, timely response to FDA 483 observations or warning letters; as well as, educate the audience on the essential elements of a thorough response.

Additionally, this course will review the proper structure of the response to ensure the regulatory agency's expectations are met and the submission process.

Why should you Attend: The outcome of regulatory inspections is critical to an organization's success. The FDA performs inspections to check that companies are maintaining compliance with applicable regulations and quality standards. Though you do your best to avoid it, receiving a 483 or Warning Letter is inevitable. It's important to take the observations very seriously, because you only have 15 days to submit the subsequent responses. But ensuring that you are aware and understand what the regulatory agency is expecting in the response can be a challenge. What should you include? What are the risks of not submitting an appropriate response?

Areas Covered in the Session:

  • Review regulatory policies and procedures in regard to FDA 483 observations or Warning Letters
    • Understand the importance of responding to the observations
    • Discuss timelines and potential regulatory outcomes of not submitting an appropriate response
    • Understand who is the audience
    • Understand what the regulatory agency is expecting in the response
  • Structure of the Response
    • Review the components necessary to develop a thorough response
    • Review response checklist
    • Discuss recent Regulatory observations and review associated responses
    • Response Submission and Post Response Outcomes
    • Discuss the process for submitting the response to the regulatory agency
  • Discuss when and how to provide follow-up updates to the regulatory agency post the initial response
  • Discuss post response outcomes

Who Will Benefit:
  • Quality
  • Manufacturing
  • Engineering


Speaker Profile
Kelly Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation. Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.




Your Recently Viewed Webinars

Payment Methods

Contact Us

NetZealous LLC,
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA.

Information

  Refund Policy
  +1-800-447-9407
  Fax: 302 288 6884
  support@compliance4All.com